Ypsomed Holding Valuation
YPSN Stock | CHF 367.50 2.50 0.68% |
At this time, the company appears to be overvalued. Ypsomed Holding AG maintains a prevalent Real Value of ₣318.36 per share. The last-minute price of the company is ₣367.5. Our model calculates the value of Ypsomed Holding AG from examining the company fundamentals such as Return On Asset of 0.0308, current valuation of 2.35 B, and Profit Margin of 0.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ypsomed Holding's price fluctuation is very steady at this time. Calculation of the real value of Ypsomed Holding AG is based on 3 months time horizon. Increasing Ypsomed Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ypsomed stock is determined by what a typical buyer is willing to pay for full or partial control of Ypsomed Holding AG. Since Ypsomed Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ypsomed Stock. However, Ypsomed Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 367.5 | Real 318.36 | Hype 367.5 | Naive 381.67 |
The intrinsic value of Ypsomed Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ypsomed Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ypsomed Holding AG helps investors to forecast how Ypsomed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ypsomed Holding more accurately as focusing exclusively on Ypsomed Holding's fundamentals will not take into account other important factors: Ypsomed Holding Total Value Analysis
Ypsomed Holding AG is at this time anticipated to have takeover price of 2.35 B with market capitalization of 2.53 B, debt of 110 M, and cash on hands of 12.08 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ypsomed Holding fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
2.35 B | 2.53 B | 110 M | 12.08 M |
Ypsomed Holding Investor Information
About 68.0% of the company outstanding shares are owned by insiders. The book value of Ypsomed Holding was at this time reported as 37.29. The company last dividend was issued on the 4th of July 2022. Ypsomed Holding AG had 1629:1624 split on the 16th of June 2022. Ypsomed Holding AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Ypsomed Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ypsomed Holding has an asset utilization ratio of 61.41 percent. This indicates that the Company is making ₣0.61 for each dollar of assets. An increasing asset utilization means that Ypsomed Holding AG is more efficient with each dollar of assets it utilizes for everyday operations.Ypsomed Holding Ownership Allocation
The market capitalization of Ypsomed Holding AG is ₣2.53 Billion. Ypsomed Holding AG maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.41 (%) of Ypsomed Holding AG outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Ypsomed Holding Profitability Analysis
The company reported the revenue of 464.84 M. Net Income was 23.11 M with profit before overhead, payroll, taxes, and interest of 113.82 M.About Ypsomed Holding Valuation
Our relative valuation model uses a comparative analysis of Ypsomed Holding. We calculate exposure to Ypsomed Holding's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ypsomed Holding's related companies.Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. YPSOMED HLDG operates under Medical Devices classification in Switzerland and is traded on Switzerland Exchange. It employs 1522 people.
8 Steps to conduct Ypsomed Holding's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ypsomed Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ypsomed Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ypsomed Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ypsomed Holding's revenue streams: Identify Ypsomed Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ypsomed Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ypsomed Holding's growth potential: Evaluate Ypsomed Holding's management, business model, and growth potential.
- Determine Ypsomed Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ypsomed Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Ypsomed Stock Analysis
When running Ypsomed Holding's price analysis, check to measure Ypsomed Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ypsomed Holding is operating at the current time. Most of Ypsomed Holding's value examination focuses on studying past and present price action to predict the probability of Ypsomed Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ypsomed Holding's price. Additionally, you may evaluate how the addition of Ypsomed Holding to your portfolios can decrease your overall portfolio volatility.